OPTimizing Treatment Focused Genetic Testing IN Cancer
NCT04066361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 301
Last updated 2024-01-25
Summary
This two-part randomized controlled trial aims to evaluate the impact of pre-test video education as compared to pre-test Chatbot education.
Conditions
Interventions
- OTHER
-
Chatbot
Interactive text chat designed to mirror the educational components of a traditional genetic counseling visit
- OTHER
-
Video Education
Brief video designed to mirror the educational components of a traditional genetic counseling visit
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Huma Q Rana, MD · Dana-Farber Cancer Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-19
- Primary Completion
- 2022-11-30
- Completion
- 2022-11-30
Countries
- United States
Study Locations
More Related Trials
-
SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract
NCT00006351 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
NCT00620295 ·Status: COMPLETED ·Phase: PHASE1
-
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
NCT00004095 ·Status: COMPLETED ·Phase: PHASE1
-
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
NCT00020644 ·Status: UNKNOWN ·Phase: PHASE1
-
Testing Gene PilotLX With Latinx Cancer Patients
NCT06476938 ·Status: RECRUITING ·Phase: NA
-
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
NCT00066781 ·Status: COMPLETED ·Phase: PHASE2
-
Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
NCT00060112 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
NCT00532623 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma
NCT03656536 ·Status: TERMINATED ·Phase: PHASE3
-
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
NCT00357630 ·Status: COMPLETED ·Phase: PHASE2
-
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT05809557 ·Status: COMPLETED ·Phase: NA
-
Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
NCT00173862 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors
NCT01165905 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
NCT07043972 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
NCT05166694 ·Status: RECRUITING ·Phase: NA
-
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT00622674 ·Status: COMPLETED ·Phase: PHASE1
-
Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy
NCT02569723 ·Status: COMPLETED ·Phase: NA
-
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
NCT00588666 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer
NCT02006667 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors
NCT00887757 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Perifosine and Gemcitabine Study
NCT00398697 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
NCT04203160 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
NCT03920839 ·Status: WITHDRAWN ·Phase: PHASE1
-
Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
NCT01206426 ·Status: COMPLETED
-
Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors
NCT00021346 ·Status: COMPLETED ·Phase: PHASE1